SLC9A1 and migraine disorder: The reduction of NHE1 functional expression seems to be beneficial to conserve paracellular BBB integrity, however, the data showing facial sensitivity induced by a single, systemic dose of zoniporide raises question about the overall positive effect of NHE1 blockade in migraine/secondary headache patients.